VistaGen’s nasal spray could reduce menopausal hot flashes, new data suggests
In new Phase IIa data, VistaGen's nasal spray reduced the average number of hot flashes in women with menopause.
IDE clinical trial for artificial cervical disc completes enrollment
FogPharma doses first patient in colorectal cancer drug trial
ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC
ASCO 2023: Precigen reports positive early data for CAR-T therapy
ANeuroTech receives FDA approval for Phase IIIb MDD drug trial
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreCocrystal receives approval from HREC for Phase I trial of Covid-19 therapy
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
More Insights
Who’s hiring who? Hiring activity related to artificial intelligence increased by 7% in the pharmaceutical industry in Q3 2022
Quarterly Hiring Update: Hiring activity related to cloud decreased by 8% in the pharmaceutical industry in Q3 2022
Who’s hiring who? Hiring activity related to cybersecurity increased by 30% in the pharmaceutical industry in Q3 2022
Quarterly Hiring Update: Hiring activity related to environmental sustainability decreased by 2% in the pharmaceutical industry in Q3 2022
Buyer's Guides
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
The future of long Covid trials
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan